No CrossRef data available.
Article contents
‘Pseudo-paraplegia': a chronic psychotic sequela of organophosphate exposure in schizophrenia
Published online by Cambridge University Press: 24 June 2014
Abstract
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Comment & Critique
- Information
- Copyright
- Copyright © Cambridge University Press 2011
References
1.
Metcalf, DR, Holmes, JH
Toxicology and physiology. EEG, psychological, and neurological alterations in humans with organophosphorus exposure.
Ann N Y Acad Sci
1969;160:357–365.
CrossRefGoogle ScholarPubMed
2.
Savage, EP, Keefe, TJ, Mounce, LM, Heaton, RK, Lewis, JA, Burcar, PJ.
Chronic neurological sequelae of acute organophosphate pesticide poisoning.
Arch Environ Health
1988;43:38–45.
CrossRefGoogle ScholarPubMed
3.
Tan, DH, Peng, SQ, Wu, YL, Wang, YM, Lu, CF, Yan, CH.
Chronic organophosphate (OP)-induced neuropsychiatric disorder is a withdrawal syndrome.
Med Hypotheses
2009;72: 405–406.
CrossRefGoogle ScholarPubMed
4.
Tandon, R, Greden, JF.
Cholinergic hyperactivity and negative schizophrenic symptoms. A model of cholinergic/ dopaminergic interactions in schizophrenia.
Arch Gen Psychiatry
1989;46:745–753.
CrossRefGoogle Scholar
5.
Scarr, E, Dean, B.
Role of the cholinergic system in the pathology and treatment of schizophrenia.
Expert Rev Neurother
2009;9:73–86.
CrossRefGoogle ScholarPubMed
6.
Ali, SF, Hasan, M, Tariq, M.
Levels of dopamine, norepinephrine & 5-hydroxytryptamine in different regions of rat brain & spinal cord following chronic administration of organophosphate pesticide dichlorvos.
Indian J Exp Biol
1979;17:424–426.
Google ScholarPubMed
7.
Geyer, MA, Vollenweider, FX.
Serotonin research: contributions to understanding psychoses.
Trends Pharmacol Sci
2008;29:445–453.
CrossRefGoogle ScholarPubMed
8.
Slotkin, TA, Seidler, FJ.
Comparative developmental neurotoxicity of organophosphates in vivo: transcriptional responses of pathways for brain cell development, cell signaling, cytotoxicity and neurotransmitter systems.
Brain Res Bull
2007;72:232–274.
CrossRefGoogle ScholarPubMed
9.
Scarr, E.
Muscarinic receptors in psychiatric disorders – can we mimic ‘health'?
Neurosignals
2009;17:298–310.
CrossRefGoogle ScholarPubMed
10.
Bennouna, M, Greene, VB, Defranoux, L.
Cholinergic hypothesis in psychosis following traumatic brain injury and cholinergic hypothesis in schizophrenia: a link?
Encephale
2007;33:616–620.
CrossRefGoogle ScholarPubMed